A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)

Exclusion Criteria

• •Diagnosis of Human herpes virus (HHV) 8-positive Diffuse large B Cell lymphoma (DLBCL)
• •Prior allogeneic Hematopoietic stem cell transplantation (HSCT)
• •Autologous stem cell transplant within 12 weeks of chimeric antigen receptor (CAR) T cell infusion
• •Uncontrolled active infections
• •History of deep vein thrombosis or pulmonary embolism within six months of infusion (except for line associated deep vein thrombosis \[DVT\])
• •History of stroke, unstable angina, myocardial infarction, congestive heart failure ( New York Heart Association \[NYHA\] Class III or IV), severe cardiomyopathy or ventricular arrhythmia requiring medication or mechanical control within 6 months of screening
• •History of a seizure disorder, dementia, cerebellar disease or neurodegenerative disorder
• •Known history or prior diagnosis of optic neuritis or other immunologic or inflammatory disease affecting the central nervous system
• •Active central nervous system (CNS) involvement by malignancy
• •Current active liver or biliary disease (except for Gilbert's syndrome or asymptomatic gallstones)